Literature DB >> 19836543

A new easy method for specific measurement of active myeloperoxidase in human biological fluids and tissue extracts.

T Franck1, S Kohnen, K Zouaoui Boudjeltia, P Van Antwerpen, A Bosseloir, A Niesten, O Gach, M Nys, G Deby-Dupont, D Serteyn.   

Abstract

The SIEFED ("Specific Immunological Extraction Followed by Enzymatic Detection") method already developed for the specific detection of the activity of equine myeloperoxidase (MPO) was adapted for the specific measurement of active human MPO in biological fluids or tissue extracts. The method consists of the extraction of MPO from aqueous solutions by immobilized anti-MPO antibodies followed by a washing (to eliminate the extraction medium and the biological fluid with their possible interfering molecules) and the measurement of the activity of MPO with a detection system containing a fluorogenic substrate, H(2)O(2) and nitrite ions as reaction enhancer. The SIEFED was applied to study active MPO in human biological fluids (plasma, bronchoalveolar lavage fluid and supernatant from carotids extracts). The SIEFED for human MPO has a sensitivity limit of 0.080 mU/mL and showed good precision with intra- and inter-assay coefficients of variation below 10 and 20% respectively within a broad range of MPO activities establish from 0.156 to 473 mU/mL. The SIEFED for human MPO will be useful for the specific detection of active MPO in complex fluids and can be complementary to an ELISA to determine an active/total MPO ratio in healthy volunteers and patients especially in case of chronic or acute inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19836543     DOI: 10.1016/j.talanta.2009.07.052

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  11 in total

1.  A rapid bioluminescence assay for measuring myeloperoxidase activity in human plasma.

Authors:  Reece J Goiffon; Sara C Martinez; David Piwnica-Worms
Journal:  Nat Commun       Date:  2015-02-10       Impact factor: 14.919

2.  Fast Blue RR-Siloxane Derivatized Materials Indicate Wound Infection Due to a Deep Blue Color Development.

Authors:  Doris Schiffer; Gregor Tegl; Robert Vielnascher; Hansjoerg Weber; Rainer Schoeftner; Herfried Wiesbauer; Eva Sigl; Andrea Heinzle; Georg M Guebitz
Journal:  Materials (Basel)       Date:  2015-09-25       Impact factor: 3.623

3.  Sevoflurane modulates the release of reactive oxygen species, myeloperoxidase, and elastase in human whole blood: Effects of different stimuli on neutrophil response to volatile anesthetic in vitro.

Authors:  Grégory Minguet; Thierry Franck; Jean Joris; Didier Serteyn
Journal:  Int J Immunopathol Pharmacol       Date:  2017-10-31       Impact factor: 3.219

Review 4.  The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture.

Authors:  Nathaniel Teng; Ghassan J Maghzal; Jihan Talib; Imran Rashid; Antony K Lau; Roland Stocker
Journal:  Redox Rep       Date:  2016-11-25       Impact factor: 4.412

5.  Collagen catabolism through Coll2-1 and Coll2-1NO2 and myeloperoxidase activity in marathon runners.

Authors:  Yves Henrotin; Alain Labasse; Thierry Franck; Alain Bosseloir; Thierry Bury; Michelle Deberg
Journal:  Springerplus       Date:  2013-03-08

Review 6.  Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies.

Authors:  Cédric Delporte; Pierre Van Antwerpen; Luc Vanhamme; Thierry Roumeguère; Karim Zouaoui Boudjeltia
Journal:  Mediators Inflamm       Date:  2013-07-24       Impact factor: 4.711

7.  Measuring myeloperoxidase activity in biological samples.

Authors:  Benjamin Pulli; Muhammad Ali; Reza Forghani; Stefan Schob; Kevin L C Hsieh; Gregory Wojtkiewicz; Jenny J Linnoila; John W Chen
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240

8.  Myeloperoxidase-dependent LDL modifications in bloodstream are mainly predicted by angiotensin II, adiponectin, and myeloperoxidase activity: a cross-sectional study in men.

Authors:  Karim Zouaoui Boudjeltia; Cédric Delporte; Pierre Van Antwerpen; Thierry Franck; Didier Serteyn; Nicole Moguilevsky; Martine Raes; Luc Vanhamme; Michel Vanhaeverbeek; Alain Van Meerhaeghe; Thierry Roumeguère
Journal:  Mediators Inflamm       Date:  2013-11-18       Impact factor: 4.711

9.  Differential Effects of E-Cigarette on Microvascular Endothelial Function, Arterial Stiffness and Oxidative Stress: A Randomized Crossover Trial.

Authors:  Martin Chaumont; Benjamin de Becker; Wael Zaher; Antoine Culié; Guillaume Deprez; Christian Mélot; Florence Reyé; Pierre Van Antwerpen; Cédric Delporte; Nadia Debbas; Karim Zouaoui Boudjeltia; Philippe van de Borne
Journal:  Sci Rep       Date:  2018-07-10       Impact factor: 4.379

10.  Neutrophil Phenotypes in Coronary Artery Disease.

Authors:  Patrick Maréchal; Julien Tridetti; Mai-Linh Nguyen; Odile Wéra; Zheshen Jiang; Maxime Gustin; Anne-Françoise Donneau; Cécile Oury; Patrizio Lancellotti
Journal:  J Clin Med       Date:  2020-05-25       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.